Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Abbv crawled date : 2021 - 06 - 09 save search
Global Psychedelic Drugs Market Research Report 2021-2026: Focus on Gamma-hydroxybutyrate, MDMA, Ketamine, Psilocybin, Others
Published: 2021-06-09 (Crawled : 20:00) - prnewswire.com
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: 0.25%
H: 0.95%
C: 0.65%
ABBV | News | $168.21 -0.78% 1.2M
|
Health Technology
|
| O: 0.32%
H: 2.3%
C: 1.64%
CMPS | $7.98 -3.27% 570K
|
Health Technology
|
| O: 2.77%
H: 1.02%
C: -1.5%
drug research ketamine psilocybin
Kojin Therapeutics Launches with $60 Million Series A to Develop New Category of Drugs Based on Cell State Biology
Published: 2021-06-09 (Crawled : 12:00) - biospace.com/
ABBV | News | $168.21 -0.78% 1.2M
|
Health Technology
|
| O: 0.48%
H: 1.36%
C: 0.99%
drug
Caraway Therapeutics Establishes Collaboration with AbbVie to Develop Novel Small Molecule Therapeutics for Parkinson’s Disease and Other Related Disorders
Published: 2021-06-09 (Crawled : 11:00) - biospace.com/
ABBV | News | $168.21 -0.78% 1.2M
|
Health Technology
|
| O: 0.48%
H: 1.36%
C: 0.99%
disease collaboration parkinson
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-09 (Crawled : 10:51) - fda.gov
PFE | News 4 | $26.25 -0.27% 9.9M
|
Health Technology
|
| O: 0.39%
H: 2.15%
C: 2.08%
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 0.29%
H: 2.43%
C: 2.1%
BMY | $48.825 -0.34% 9.7M
|
Health Technology
|
| O: 0.5%
H: 2.39%
C: 2.16%
ABBV | News | $168.21 -0.78% 1.2M
|
Health Technology
|
| O: 0.48%
H: 1.36%
C: 0.99%
XERS | $1.765 -0.84% 420K
|
Health Technology
|
| O: 7.18%
H: 4.52%
C: -4.07%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 0.88%
H: 0.74%
C: 0.5%
OTIC | $0.077
|
Health Technology
|
| O: -0.84%
H: 5.93%
C: 0.42%
OMER | $3.05 -1.29% 120K
|
Health Technology
|
| O: 0.95%
H: 2.0%
C: 0.25%
GILD | $66.99 -0.06% 3.3M
|
Health Technology
|
| O: 0.09%
H: 2.4%
C: 1.6%
BCRX | News | $4.225 -3.54% 2.3M
|
Health Technology
|
| O: 0.82%
H: 2.39%
C: -1.11%
AMGN | News | $274.15 0.22% 900K
|
Health Technology
|
| O: 0.46%
H: 1.42%
C: 0.67%
$ 63.41 Billion growth in Monoclonal Antibodies Market 2021-2025 | Targeted therapeutic mechanism of action to boost growth | Technavio
Published: 2021-06-09 (Crawled : 06:00) - prnewswire.com
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
|
| O: 1.91%
H: 0.96%
C: 0.9%
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: 0.37%
H: 1.09%
C: 0.98%
GSK | News | $40.755 -1.18% 660K
|
Health Technology
|
| O: 1.24%
H: 0.64%
C: 0.64%
ABBV | News | $168.21 -0.78% 1.2M
|
Health Technology
|
| O: 0.48%
H: 1.36%
C: 0.99%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 0.88%
H: 0.74%
C: 0.5%
AZN | News | $71.26 0.58% 3.8M
|
Health Technology
|
| O: 1.15%
H: 1.22%
C: 1.12%
monoclonal antibodies growth antibody
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.